HWHelen H. Wang

Helen H. Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Helen H. Wang has a total of 64 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Conservation of the tumour microenvironment across organs and species

    by Michael Januszyk, John M. Lu, Maria Korah, Serena L. Jing, Peter Y. Xie, Mahsa Fallah, Benjamin Pham, Jason L. Guo, Charlotte E. Berry, Helen H. Wang, et al.

    Current understanding of the host tissue response to solid tumours is largely based on investigations of tumour types in isolation1. Given the breadth and diversity of human tumour pathology and contributions of tumour microenvironment (TME) cells to disease progression, pan-cancer analysis is needed to bridge major themes of stromal and immune cell evolution. To date, however, efforts to compare the TME response across cancers have been limited in scope2,3. Here we conduct a comprehensive pan-cancer analysis by algorithmically screening thousands of publicly available single-cell transcriptomic datasets for stromal and immune signatures across species and tissue types. We demonstrate conserved hallmarks of host cell transcriptional programming in response to malignancy across 42 cancer types in more than 2,000 human and mouse tumour samples. These findings are codified as an interactive web atlas ( tmeatlas.stanford.edu ) and software package (scTME) that will serve as practical resources for the systematic interrogation of the TME in tumours.


  • Transcriptomic reprogramming screen identifies SRSF1 as a regulator of aging

    by Alexandru M. Plesa, Sascha Jung, Helen H. Wang, Fawad Omar, Michael Shadpour, David Choy Buentello, Maria C. Perez-Matos, Naftali Horwitz, George Cai, Zhen Kai Ngian, et al.

  • Open Access

    Characterizing Fibroblast Heterogeneity in Diabetic Wounds Through Single-Cell RNA-Sequencing

    by Helen H. Wang, Maria Korah, Serena L. Jing, Charlotte E. Berry, Michelle F. Griffin, Michael T. Longaker, Michael Januszyk

    Diabetes mellitus is an increasingly prevalent chronic metabolic disorder characterized by physiologic hyperglycemia that, when left uncontrolled, can lead to significant complications in multiple organs. Diabetic wounds are common in the general population, yet the underlying mechanism of impaired healing in such wounds remains unclear. Single-cell RNA-sequencing (scRNAseq) has recently emerged as a tool to study the gene expression of heterogeneous cell populations in skin wounds. Herein, we review the history of scRNAseq and its application to the study of diabetic wound healing, focusing on how innovations in single-cell sequencing have transformed strategies for fibroblast analysis. We summarize recent research on the role of fibroblasts in diabetic wound healing and describe the functional and cellular heterogeneity of skin fibroblasts. Moreover, we highlight future opportunities in diabetic wound fibroblast research, with a focus on characterizing distinct fibroblast subpopulations and their lineages. Leveraging single-cell technologies to explore fibroblast heterogeneity and the complex biology of diabetic wounds may reveal new therapeutic targets for improving wound healing and ultimately alleviate the clinical burden of chronic wounds.


  • Open Access

    MegaGate: A toxin-less gateway molecular cloning tool

    by Christian Kramme, Alexandru M. Plesa, Helen H. Wang, Bennett Wolf, Merrick Pierson Smela, Xiaoge Guo, Richie E. Kohman, Pranam Chatterjee, George M. Church


  • Open Access

    An integrated pipeline for mammalian genetic screening

    by Christian Kramme, Alexandru M. Plesa, Helen H. Wang, Bennett Wolf, Merrick Pierson Smela, Xiaoge Guo, Richie E. Kohman, Pranam Chatterjee, George M. Church


  • K+ channel inhibition accelerates intestinal epithelial cell wound healing

    by Margaret M. Lotz, Helen Wang, Jaekyung Cecilia Song, Susan E. Pories, Jeffrey B. Matthews

    Restitution is the process by which superficial interruptions in the gastrointestinal mucosa are repaired by the flattening and spreading of epithelial cells surrounding the damage. During this process, mucosal epithelial cells undergo extensive reshaping and cytoskeletal remodeling. K+ channels, located primarily on the basolateral surface of gut epithelial cells, are central to both actin polymerization, via their control of membrane potential, and cell volume regulation. We questioned whether K+ channels are involved in restitution using an in vitro model of intestinal epithelium, monolayers of the human colon carcinoma cell line T84. We report that pharmacologic K+ channel inhibition accelerates wound healing in T84 cell monolayers. Both Ca++‐dependent and constitutively active channels are involved, as indicated by the sensitivity to clotrimazole, charybdotoxin, and barium. The ability of clotrimazole to accelerate wound resealing was also observed in Caco‐2 cell sheets. Pharmacologic stimulation of K+ channel activity had no effect on the repair rate. Analysis of the resealing process by time lapse and confocal microscopy revealed that K+ channel inhibitors abolished the initial wound retraction, briefly accelerated the repair rate, and altered the shape of the cell sheet abutting the injury during the early phase of resealing. We hypothesize that K+ channel inactivation interrupts the coregulation of f‐actin polymerization and volume control that is initiated by the healing process.